Legal status in the United States

Is Exenatide legal?

Read at FDA, DEA and WADAPublished by PepVault

Exenatide is FDA-approved (Byetta, Bydureon and Bydureon BCise, first in 2005), is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 18, 2026.

Exenatide at a glance

CheckStatus, read Nov 18, 2026
FDA approvalApproved (Byetta, 2005)
CompoundingComponent of an approved drug (503A condition)
DEA scheduleNot controlled
Sport (WADA)Not named on the list

FDA approval

Exenatide was FDA-approved as Byetta in 2005, then as Bydureon (2012) and Bydureon BCise (2017). On Drugs@FDA, read November 18, 2026, Bydureon, Bydureon BCise and Byetta’s first application are listed as discontinued, and Byetta is listed as a prescription drug under a second application (NDA 021919); Byetta’s label on DailyMed gives its pens marketing end dates of November 30 and December 31, 2026.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

Exenatide is the active ingredient of FDA-approved drugs (Byetta, Bydureon). FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name exenatide.

The source: “Are components of FDA-approved drug products if an applicable USP or NF monograph does not exist”

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

The 2026 Prohibited List doesn’t name exenatide or GLP-1 drugs, and S0, the class for unapproved substances, doesn’t reach an approved drug.

What this means and doesn’t

This page reports what the agencies’ own pages said about Exenatide in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Exenatide FDA approved?

    Exenatide was FDA-approved as Byetta in 2005, then as Bydureon (2012) and Bydureon BCise (2017). On Drugs@FDA, read November 18, 2026, Bydureon, Bydureon BCise and Byetta’s first application are listed as discontinued, and Byetta is listed as a prescription drug under a second application (NDA 021919); Byetta’s label on DailyMed gives its pens marketing end dates of November 30 and December 31, 2026.

  • Is Exenatide a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is Exenatide banned in sport?

    The 2026 Prohibited List doesn’t name exenatide or GLP-1 drugs, and S0, the class for unapproved substances, doesn’t reach an approved drug.

  • What does FDA say about compounding Exenatide?

    Exenatide is the active ingredient of FDA-approved drugs (Byetta, Bydureon). FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name exenatide.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo